跳转至内容
Merck
  • Mutation-free baby born from a mitochondrial encephalopathy, lactic acidosis and stroke-like syndrome carrier after blastocyst trophectoderm preimplantation genetic diagnosis.

Mutation-free baby born from a mitochondrial encephalopathy, lactic acidosis and stroke-like syndrome carrier after blastocyst trophectoderm preimplantation genetic diagnosis.

Mitochondrion (2014-08-28)
Björn Heindryckx, Jitesh Neupane, Mado Vandewoestyne, Christodoulos Christodoulou, Yens Jackers, Jan Gerris, Etienne Van den Abbeel, Rudy Van Coster, Dieter Deforce, Petra De Sutter
摘要

To investigate the applicability of preimplantation genetic diagnosis (PGD), we used trophectoderm (TE) biopsy to determine the mutation load in a 35-year-old female with mitochondrial encephalopathy, lactic acidosis and stroke-like syndrome (MELAS). Transfer of a mutation-free blastocyst gave birth to a healthy boy with undetectable mutation in any of the analyzed tissues. We found strong correlation among TE cells (r=0.90) within blastocysts and also between cytoplasmic fragments and TE (r=0.95). This is the first case of mutation-free baby born from a MELAS patient after TE biopsy and supports the applicability of blastocyst PGD for patients with mtDNA disorders to establish healthy offspring.

材料
货号
品牌
产品描述

Sigma-Aldrich
甲酰胺, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
甲酰胺, BioReagent, ≥99.5% (GC), for molecular biology
Sigma-Aldrich
甲酰胺, BioUltra, for molecular biology, ≥99.5% (T)
Sigma-Aldrich
N,O-双(三甲基甲硅烷基)乙酰胺, synthesis grade, ≥95%
Sigma-Aldrich
甲酰胺, spectrophotometric grade, ≥99%
Sigma-Aldrich
促黄体激素释放激素, ≥97% (HPLC)
Sigma-Aldrich
Luteinizing hormone releasing hormone salmon, ≥97% (HPLC)
Sigma-Aldrich
甲酰胺, ACS reagent, ≥99.5%
Supelco
N,O-双(三甲基甲硅烷基)乙酰胺, for GC derivatization, LiChropur, ≥98.5% (GC)